SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: gcrispin who wrote (682)5/19/2005 8:39:00 AM
From: Icebrg  Read Replies (1) | Respond to of 946
 
It was indeed an interesting exchange. Bianco evidently was not able to grasp the consequences while on air.

I am sure he will order this review first thing in the morning today. If they are able to disqualify some of the Eastern Europe patients, they should do better efficacy-wise. Which seems to be what Dr. Gabrielson wanted to suggest, although I find the forum for making such a suggestion somewhat strange.

Erik



To: gcrispin who wrote (682)5/19/2005 12:12:13 PM
From: Ian@SI  Read Replies (1) | Respond to of 946
 
The tone in his voice when he talked about EE as a clinical trial site seemed to me to be somewhere between disdain and animosity.

Does anyone have any comment on CTIC's feeling that they can probably successfully file an NDA based upon the current protocol wording. i.e. - superiourity over Vin is sufficient.
???


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News